Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
10/2002
10/03/2002WO2002076950A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
10/03/2002WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/03/2002WO2002076438A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
10/03/2002WO2002076404A2 Fatty alcohol drug conjugates
10/03/2002WO2002076177A2 Design and synthesis of optimized ligands for ppar
10/03/2002WO2001019800A9 Mediators of hedgehog signaling pathways, compositions and uses related thereto
10/03/2002US20020143191 Novel stabilized activated derivatives of carbamic acid, their process of preparation and their use for the preparation of ureas
10/03/2002US20020143190 Methods of synthesizing heteroatom-bearing ligands and intermediate used therefor
10/03/2002US20020143179 For therapy of disorder of the central nervous system which responds to dopamine D3 ligands such as schizophrenia, depression, neuroses and psychoses
10/03/2002US20020143044 Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
10/03/2002US20020143026 Induce mitotic arrest thereby making them useful as anti-cancer agents; also for therapy of diseases which can be treated by inducing mitotic arrest
10/03/2002US20020143024 As antihypertensive agents; for therapy of disorders related to renal, glomerular and mesangial cell function; therapy of endotoxemia or endotoxin shock as well as hemorrhagic shock; useful in alleviation of pain associated cancer
10/03/2002US20020143021 Administering to vertebrate an effective tumor-growth-inhibiting phenylahistin compound or prodrug ester for therapy of cancer
10/03/2002US20020143017 Pyridazinone aldose reductase inhibitors
10/03/2002US20020142967 Thrombin inhibitors
10/03/2002CA2441790A1 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
10/03/2002CA2441334A1 .delta.1 pyrrolines
10/03/2002CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/02/2002WO2001077084A1 Substituted phenyluracils
10/02/2002EP1246006A2 Dye-forming coupler, silver halide photographic light-sensitive material and azomethine dye compound
10/02/2002EP1245568A1 Sulfonyl derivatives of amino acids and their use as inhibitors of dipeptidyl-peptidase IV (DPP IV)
10/02/2002EP1245229A2 Methods and compositions for inhibition of angiogenesis
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244639A1 2-cyclohexyl benzimidazole nmda/nr2b antagonists
10/02/2002EP1244637A1 Butyne diol derivatives
10/02/2002EP1244636A1 Benzimidazoles, production thereof and the use thereof as antithrombotic
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002EP1244446A1 Thrombopoietin mimetics
10/02/2002EP0804196B1 Use of serotonin antagonists (5ht 3) for treating fibromyalgia
10/02/2002EP0706521B1 Imides as tnf alpha inhibitors
10/02/2002CN1372553A Novel thiazine or pyrazine derivatives
10/02/2002CN1372552A Pyrimidine derivatives and herbicides containing the same
10/02/2002CN1372547A Aminoalkoxy carbazoles for the treatment of CNS diseases
10/02/2002CN1372546A Fused pyrrolecarboxamides GABA brain receptor ligands
10/02/2002CN1372545A 吲哚衍生物 Indole derivatives
10/02/2002CN1372541A Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
10/02/2002CN1091768C Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
10/02/2002CN1091595C Use of a compound in preparing medicine for curing dyspepsia
10/02/2002CA2404759A1 Substituted phenyluracils
10/01/2002US6458985 Use of compressed CO2 in chemical reactions
10/01/2002US6458821 The novel substances are suitable for controlling diseases. interesting properties as potential neuroleptics and antidepressants
10/01/2002US6458800 1,2-annelated quinoline derivatives
10/01/2002US6458792 Medicament for the treatment of inflammatory, immunological, bronchopulmonary, cardiovascular, oncological or cns-degenerative disorders.
10/01/2002US6458788 4-hydroxycinnoline-3-carboxyamides as antiviral agents
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458784 Vitronectin receptor antagonists
10/01/2002US6458783 Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase
10/01/2002US6458768 Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
10/01/2002CA2228370C Piperazino derivatives as neurokinin antagonists
10/01/2002CA2209018C Sulfonamides and their use
10/01/2002CA2059708C Indole derivatives
09/2002
09/30/2002CA2379791A1 Novel triazine compounds useful as sorbitol dehydrogenase inhibitors
09/26/2002WO2002074777A2 Pyranocoumarin compounds as a novel pharmacophore with anti-tb activity
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074764A2 Piperazine derivatives and their use as 5-ht1b ligands
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074753A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074741A1 Pyrrolidine ester derivatives with oxytocin modulating acitvity
09/26/2002WO2002074050A2 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
09/26/2002WO2002062796A8 Epindolidione pigments
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002038544A3 3-substituted oxindole beta 3 agonists
09/26/2002WO2002036116A3 Tripeptidyl peptidase inhibitors
09/26/2002WO2002024685A8 Indole derivatives and their use as antifungal and/or antiparasitic agents
09/26/2002US20020137932 Treating autoimmune diseases, Alzheimer's disease, atherosclerosis, osteoporosis, and asthma
09/26/2002US20020137931 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
09/26/2002US20020137929 1 - (3-heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
09/26/2002US20020137784 Guanidine derivatives
09/26/2002US20020137769 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
09/26/2002US20020137755 Tyrosine kinase inhibitors
09/26/2002US20020137747 Block cytokine production via inhibition of p38 kinase; triamino-s-triazine compounds; treating rheumatoid arthritis
09/26/2002US20020137687 Novel compounds that inhibit tryptase activity
09/26/2002US20020137054 AXOR35, a G-protein coupled receptor
09/26/2002DE10113965A1 New tetrazolylphenyl-substituted 1-pyrroline derivatives useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
09/26/2002CA2444526A1 Metalloproteinase inhibitors
09/26/2002CA2441822A1 Asymmetric synthesis of (s, s, r)-(-)-actinonin and its analogs and uses therefor
09/26/2002CA2440632A1 Metalloproteinase inhibitors
09/26/2002CA2440631A1 Metalloproteinase inhibitors
09/26/2002CA2440475A1 Metalloproteinase inhibitors
09/26/2002CA2440405A1 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi
09/26/2002CA2440002A1 Pyrrolidine ester derivatives with oxytocin modulating activity
09/25/2002EP1243582A1 Quinoline and quinazoline derivatives and drugs containing the same
09/25/2002EP1242427A1 Novel piperidine and piperazine derivatives
09/25/2002EP1242409A2 Substituted bisindolylmaleimides
09/25/2002EP1242408A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
09/25/2002EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors
09/25/2002EP1242405A1 Method for producing 4-(heteroaryl-methyl)-halogen-1(2h)-phthalazinones
09/25/2002EP1242402A2 Novel compounds
09/25/2002EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
09/25/2002EP1242385A1 Cytokine, especially tnf-alpha, inhibitors
09/25/2002EP1242374A1 Acryloyl peptidic derivatives, process for their preparation and their use as antitumor agents
09/25/2002EP1242081A1 Caspases and apoptosis
09/25/2002EP1242076A1 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists
1 ... 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 ... 626